Biofrontera Inc
Change company Symbol lookup
Select an option...
BFRI Biofrontera Inc
VERU Veru Inc
CPNG Coupang Inc
BELFB Bel Fuse Inc
CTKYY CooTek (Cayman) Inc
WAB Westinghouse Air Brake Technologies Corp
HMBL Humbl Inc
LGDTF Liberty Gold Corp
RGS Regis Corp
AMX America Movil SAB de CV

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Biofrontera Inc. is a biopharmaceutical company. The Company is specialized in the commercialization of pharmaceutical products for the treatment of dermatological conditions for the diseases caused primarily by exposure to sunlight that result in sun damage to the skin. Its products focus on the treatment of actinic keratoses, which are skin lesions that lead to skin cancer. It also markets a topical antibiotic for treatment of impetigo, a bacterial skin infection. The Company’s principal product is Ameluz, which is a prescription drug for use in combination with its medical device, the BF-RhodoLED lamp, for photodynamic therapy (PDT) in the United States for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The Company’s other product include Xepi for the treatment of impetigo, a common skin infection, due to Staphylococcus aureus or streptococcus pyogenes.

Closing Price
Day's Change
-0.0025 (-0.25%)
B/A Size
Day's High
Day's Low

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    12:58p ET 11/25/22
  • Last (size)
  • 52-Wk Range
    0.8171 - 14.63
  • (12/21/21 - 11/09/22)
  • 137.3%
  • Market Cap
  • Shares Outstanding
  • -1.12
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 7.57
  • (% of float 11/15/22)

Latest News

November 21, 2022
8:48 am ET
Globe Newswire
November 14, 2022
8:45 am ET
Globe Newswire
November 10, 2022
11:52 am ET
Globe Newswire
November 08, 2022
4:45 pm ET
Globe Newswire
October 31, 2022
8:55 am ET
Globe Newswire
October 24, 2022
7:45 am ET
Globe Newswire
October 20, 2022
11:40 am ET
Globe Newswire
October 18, 2022
10:30 am ET
Globe Newswire
October 14, 2022
8:40 am ET
Globe Newswire
October 12, 2022
2:00 pm ET
Globe Newswire
October 05, 2022
11:03 pm ET
Globe Newswire
September 29, 2022
10:04 am ET
Globe Newswire
September 26, 2022
8:30 am ET
Globe Newswire
September 13, 2022
8:30 am ET
Globe Newswire
September 06, 2022
10:31 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.